Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists

Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC23318 SCH 529074 Featured
SCH 529074 is a small molecule mutant p53 reactivator that binds p53 DNA binding domain with Kd of 1-2 uM.
More description
DC41017 AZ12672857 Featured
AZ12672857 is an orally active inhibitor of EphB4 (IC50=1.3 nM) and Src kinases. AZ12672857 shows good inhibition of proliferation of c-Src transfected 3T3 cells (IC50=2 nM) as well as autophosphorylation of EphB4 in transfected CHO-K1 cells (IC50=9 nM).
More description
DC12384 LF3 Featured
LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 with an IC50 less than 2 μM.
More description
DC22506 Merck60 Featured
Merck60 (BRD 6929, Compound-60) is a potent, selective and brain-penetrant inhibitor of HDAC1 and HDAC2 with IC50 of 1 nM and 8 nM respectively.
More description
DC22534 PI4KIIIbeta-IN-10 Featured
A potent and selective type III phosphatidylinositol 4-kinase (PI4KIIIβ) inhibitor with IC50 of 3.6 nM.
More description
DC42419 Antineoplaston A10 Featured
Antineoplaston A10 is a naturally occurring substance in the human body that that can be potentially used for the treatment of glioma, lymphoma, astrocytoma and breast cancer. The main ingredient active of antineoplaston A10 (Phenylacetylglutamine, PG) inhibits RAS and promotes apoptosis.
More description
DC36084 Aspalatone Featured
Aspalatone is an anti-platelet aggregator (antithrombotic) that has been shown to prolong bleeding time in the mouse model. Aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy.
More description
DCC1281 (E/Z)-CCR-11 Featured
(E/Z)-CCR-11 (Comp 12) is a selective CD38 inhibitor, with an IC50 of 20.8 μM against CD38 cyclase. (E/Z)-CCR-11 promotes increases in cellular NAD+ levels and interferon γ.
More description
DC42747 NPD10084 Featured
Novel inhibitor of PKM2-regulated signaling, suppressing non-glycolytic PKM2-regulated signaling in cancer cells
More description
DC36960 Ameltolide Featured
Ameltolide, a 4-aminobenzamide derivative, is an anticonvulsant agent which has been shown to be effective at inhibiting seizures in animal models.
More description
DCC2206 Gac0003a4 Featured
Novel LXR inverse agonist, functioning as LXR a degrader, significantly reducing LXR protein levels in PDAC cell lines
More description
DC23647 LUF7346 Featured
LUF7346 is a novel hERG allosteric modulator that slows IKr deactivation and positively shifting IKr inactivation.
More description
DCC5479 Vuf10497 Featured
VUF10497 is a potent histamine H4 receptor (H4R) inverse agonist with anti-inflammatory activity.
More description
DC72995 ING-1466 Featured
ING-1466 is an orally active entry inhibitor of influenza A viruses (IAVs) with EC50 of 0.18 uM against IAV H1N1 (PR8-NS1-Gluc), binds to hemagglutinin (HA) and blocks HA-mediated viral infection.
More description
DCC3952 Oxiperomide Featured
Dual dopamine D2 and muscarinic M1 receptor ligand with putative antipsychotic and pro-cognitive potential
More description
DCC5447 Vu0366248 Featured
VU0366248 is a mGlu5 negative allosteric modulator.
More description
DC73117 BAY 1892005 Featured
BAY 1892005 is a small molecule that modulate mutant p53 condensation and nuclear accumulation, binds covalently to mutant p53R175H and p53Y220C and shows stabilization of p53WT and p53Y220C, exhibits anti-proliferative activity in a set of cell lines wit
More description
DC12292 Cl-amidine hydrochloride Featured
Cl-amidine (hydrochloride) is a peptidylarginine deminase (PAD) inhibitor, with an IC50 5.9 μM for PAD4.
More description
DCC1351 Cga-jk3 Featured
CGA-JK3 is CGA-JK3 is an ATP-competitive inhibitor of IKKβ-catalyzed kinase activity. CGA-JK3 inhibits IκBα phosphorylation in LPS (HY-D1056) - induced RAW 264.7 cells.
More description
DC34390 CCCI-01 Featured
CCCI-01 is an inhibitor of centrosome clustering in cancer cells.
More description
DC33537 Chlorfenson Featured
Chlorfenson is used to treat onychomycosis (nail fungus) as the primary indication.
More description
DCC5423 Setmelanotide Tfa Salt Featured
Novel highly-selective melanocortin-4 receptor (MC4R) agonist, increasing resting energy expenditure in obese individuals
More description
DCC4245 Prmt5-in-c17 Featured
Novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor
More description
DC8209 SD-70 Featured
A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program, in part by inhibition of the demethylase KDM4C (IC50=30 uM).
More description
DC42722 NSC47924 Featured
Novel 37/67kDa laminin receptor (LR) inhibitor, affecting both the direct 37/67kDa LR-PrP(C) interaction in vitro and the formation of the immunocomplex in live cells, inducing a progressive internalization of 37/67kDa LR and stabilization of PrP(C) on th
More description
DCC3965 P-2281 Featured
Novel potent inhibitor of mTOR activity, significantly suppressing macroscopic and histologic abnormalities associated with chemically-induced murine ulcerative colitis.
More description
DC20831 BRD2492 Featured
BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively) that displays excellent selectivity versus HDAC3 (IC50=2.08 uM, ≥110-fold selectivity) and all other HDAC isoforms, increases caspase-3 activation..
More description
DC33606 CTX-0124143 Featured
CTX-012414 is a KAT6A inhibitor with IC50 value of 0.49 μM and KD value of 0.38 -M.
More description
DC37370 Sulphenone Featured
Sulphenone is a chemical that can be used for the control of mite. .
More description
DCC2356 Gsk1733953a Featured
Novel Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X